ARCUTIS BIOTHERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 85415000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-03-31) |
| Status | current |
| Entity | ARCUTIS BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:04:57.915266+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f8e49214-1f52-4ee7-86f7-4c758fd7604c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001787306-25-000092Retrieved: 2026-08-19T18:04:57.915266+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001787306/accounts-receivable/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f8e49214-1f52-4ee7-86f7-4c758fd7604c
History
- no predecessors — first report